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Abstract
Background: We compared gene expression profiles in acutely dissected aorta with those in normal control aorta.
Materials and methods: Ascending aorta specimen from patients with an acute Stanford A-dissection were taken
during surgery and compared with those from normal ascending aorta from multiorgan donors using the BD Atlas™
Human1.2 Array I, BD Atlas™ Human Cardiovascular Array and the Affymetrix HG-U133A GeneChip®. For analysis only genes
with strong signals of more than 70 percent of the mean signal of all spots on the array were accepted as being expressed.
Quantitative real-time polymerase chain reaction (RT-PCR) was used to confirm regulation of expression of a subset of
24 genes known to be involved in aortic structure and function.
Results: According to our definition expression profiling of aorta tissue specimens revealed an expression of 19.1% to
23.5% of the genes listed on the arrays. Of those 15.7% to 28.9% were differently expressed in dissected and control
aorta specimens. Several genes that encode for extracellular matrix components such as collagen IV α2 and -α5, collagen
VI α3, collagen XIV α1, collagen XVIII α1 and elastin were down-regulated in aortic dissection, whereas levels of matrix
metalloproteinases-11, -14 and -19 were increased. Some genes coding for cell to cell adhesion, cell to matrix signaling
(e.g., polycystin1 and -2), cytoskeleton, as well as several myofibrillar genes (e.g., α-actinin, tropomyosin, gelsolin) were
found to be down-regulated. Not surprisingly, some genes associated with chronic inflammation such as interleukin -2, -
6 and -8, were up-regulated in dissection.
Conclusion: Our results demonstrate the complexity of the dissecting process on a molecular level. Genes coding for
the integrity and strength of the aortic wall were down-regulated whereas components of inflammatory response were
up-regulated. Altered patterns of gene expression indicate a pre-existing structural failure, which is probably a
consequence of insufficient remodeling of the aortic wall resulting in further aortic dissection.
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Background
Aortic dissection is a life threatening disease developing
without any warning. Modern diagnostic methods, such
as computed or magnetic resonance tomography, are able
to show an aortic wall hematoma at the acute onset of the
disease. This hematoma develops to aortic wall dissection
over time. It is proposed that bleeding of the vasa vasorum
presents the first step of dissection [1,2]. Subsequently
intimal tears in the aortic wall will develop later forming
a connection within the aortic wall to the aortic blood
stream, which at the end results in two blood stream chan-
nels, the true and false aortic lumen.
Little is known about the underlying defects of aortic dis-
section. Patients with heritable connective disorders, such
as Marfan-syndrome patients with a defect of the glyco-
protein fibrillin-1, and Ehlers-Danlos-syndrome patients
with a type III-procollagen disorder are known to develop
aortic dissection very early in their life [3-10]. However,
only few patients with aortic dissection suffer from one of
these syndromes as found in 134 Stanford A- and 158
Stanford B patients treated at our institution between
1984 and 2002. No patients with Ehlers-Danlos syn-
drome were found and only 9 patients (3.1%) of this
cohort fulfilled all criteria of a Marfan-syndrome. None-
theless, it is notable that some of the dissection patients
resembled Marfan patients in some aspects and demon-
strated for example joint hypermobility or skin abnormal-
ities [11]. Based on these observations the question arises:
"Does an unknown connective tissue disorder cause a pre-
disposition for aortic dissection?"
In order to answer this question, in 2002 we performed
our first comparative molecular study of acutely dissected
human aorta and normal control aorta based on measure-
ments of gene expression [12]. This previous study was
considered a pilot study with no quantitative real-time
polymerase chain reaction (RT-PCR) being regarded as the
gold standard to validate microarray data [13]. Following
the editor's recommendation to pursue the study, in the
given article we report the second expanded validation
study on a molecular basis of acute dissected aortic dis-
ease. Now, we focussed on specific cardiovascular genes
and compared the results of two different membrane-
based cDNA arrays (Clontech platform), GeneChip oligo-
nucleotide microarray (Affymetrix platform) and real-
time RT-PCR.
Patients, materials and methods
Patients' samples
For the Atlas array experiments, ascending aorta specimen
were obtained from 8 patients operated on for acute Stan-
ford type A aortic dissection (6 men 40, 41, 41, 49, 52, 54
years old and 2 women 52 and 63 years old; mean 57.5 ±
11.7 years) and from 8 multi organ donors (3 men 23, 42,
65 years old and 5 women 40, 42, 43, 45, 53 years old;
mean 44.0 ± 11.9 years). For the Affymetrix array experi-
ments, ascending aorta specimen were taken from 4 Stan-
ford type A patients (4 men 40, 41, 52, 54 years old; mean
46.8 ± 7.3 years) and from 4 multiorgan donors (2 man
65 and 40 years old; mean 53 ± 14, and 2 women 42, 45
years old; mean 42.5 ± 2.8 years). Patients' demographics
as well as specification in what experiment samples have
been analyzed are shown in Table 1. Informed written
consent was obtained from the patients or their relatives.
Samples were "snap-frozen" in liquid nitrogen and were
stored at -80°C. All studies were conducted under proto-
cols approved by the University Review Board and the
local Ethical Committee.
Total RNA isolation
Aorta tissue specimens were pulverized under liquid
nitrogen, and total RNA was extracted from grinned tissue
samples by cell lysis and subsequent binding to RNAeasy
mini spin columns including DNase I treatment (Qiagen
GmbH, Hilden, Germany). Subsequent washing and elu-
tion steps were performed according to the manufacturer's
protocol. Total RNA was quantified using UV spectropho-
tometry (Photometer ECOM 6122, Eppendorf AG, Ham-
burg, Germany) and the quality and integrity was
confirmed by electrophoresis of 0.5 μg isolated RNA on
1% formamide agarose gels. Additionally, RNA specimens
were analyzed by microcapillary electrophoresis on
LabChips using the Agilent 2100 bioanalyzer (Agilent
Technologies GmbH, Boeblingen, Germany) following
the manufacturer's instructions.
Microarray experiments
Three different gene expression studies were carried out.
For the first gene expression study, we used the BD Atlas™
Human1.2 Array I (Biosciences, Clontech Laboratories,
Heidelberg, Germany) with 1,185 single spotted probes
for known human genes. This set of genes was completed
by a second study with the BD Atlas™ Human Cardiovascu-
lar Array (BD Biosciences, Clontech Laboratories), which
contains 597 double spotted probes for genes that are spe-
cific for the cardiovascular system. Both arrays are mem-
brane-based and need to be probed with radioactive
labeled cDNAs. There are 138 genes in common between
the two Atlas arrays. All samples applied with Human 1.2
arrays were used in experiments with Cardiovascular
arrays. For genome wide screening of differentially
expressed genes, a third gene expression study was per-
formed using the Affymetrix Human Genome U133A Gene-
Chip® with 22,283 features for human genes/ESTs. For
hybridization and analysis, biotin labeled cRNA (4 dis-
sected and 4 control samples, Table 1) was used.Journal of Translational Medicine 2006, 4:29 http://www.translational-medicine.com/content/4/1/29
Page 3 of 16
(page number not for citation purposes)
Atlas experiments, cDNA probe synthesis
Radiolabeled cDNAs were prepared from 5 μg of total
RNA by incorporating 30 μCi [α-32P] dATP into cDNA by
reverse transcription using a gene specific primer mix (BD
Biosciences Clontech) as described [12]. Incorporation
rates were ~10%. Filter arrays (Atlas™ Human Broad I and
Cardiovascular) were pre-hybridized ~1 h in a hybridiza-
tion buffer (ExpressHyb, Clontech) and membranes were
hybridized for 16–18 h at 68°C. After extensive washes
membranes were exposed to a phosphor-imaging screen
(Fuji Raytest, Inc.) for 48 h. Stripped and QC-checked
membranes were reused for the next probe hybridization
for maximum three hybridizations. Reproducibility of
experiments was verified by comparing one hybridization
experiment with the same or newly prepared probe on
two or, in some cases, four different array membranes.
The results showed good reproducibility within inde-
pendent hybridizations with correlation coefficients
between 0.90 and 0.98.
Atlas experiments, data analysis
Primary data collection and analysis were carried out
using Phosphorimager (BAS-1500, Fuji, Raytest,
Straubenhardt, Germany) and Aida software (Raytest).
Thus, the amount of radioactivity on the membrane was
measured by means of a phosphorimager and converted
into corresponding gray levels of an image by the corre-
sponding software. The gray levels are supposed to be lin-
early correlated to the amount of the radioactivity on the
filter. The linearity has been experimentally checked by
comparison of measurements on a particular array during
different exposure times (8, 16, 24, 32, and 48 h of the
exposure of a filter to the phosphorimager screen). The 24
h exposure has been found appropriate to avoid the over-
saturation of the radioactive spots corresponding to the
most intensive signals. For each sample, we measured the
pixel intensity of the 597 genes spotted in duplicates on
single filter (Atlas Human Cardiovascular Array) or for
1,185 single-spotted probes (Atlas Human Total I) on two
different filters. Radioactive intensity of each spot on the
membrane was linearly digitized to gray scale with a pixel
size of 100 μm. Data were obtained as a list of intensity
values for all measured positions on the array. Areas of
arrays with obviously overlapping signals and artifacts
were manually excluded from further analyses. The back-
ground signal was subtracted using Aida software and
average pixel intensity for each pair of spots (or for each
spot) was generated.
Normalization of signal intensities obtained from differ-
ent hybridization experiments was based on the sum of
background-subtracted signal data of all expressed genes
(total intensity normalization). The total intensity nor-
malization is one of wildly used techniques that can be
used to normalize gene expression values from a single
microarray [14]. This step was performed to account for
differences in labeling and quality of RNA samples.
Finally, mean values of intensity for each gene detected
from multiple arrays were generated by the computer soft-
ware as an average array.
Additionally, normalization using ubiquitin, cytoplasmic
beta-actin (ACTB) and 60S ribosomal protein L13A
(RPL13A) housekeeping genes' expression values has
been applied to raw gene expression data and results were
compared with those from the mean value normalization.
Table 1: Patients' demographics and usage in microarray experiments
Case ID time Sex Age, years Aorta sample Human 1.2 array I Human Cardiovascular array Affymetrix HG-133A Real-PCR
p1 m 56 Stanford A used used used used
p2 m 41 Stanford A used used used used
p3 m 40 Stanford A used used used used
p4 f 52 Stanford A used used no no
p5 f 63 Stanford A used used no used
p6 m 41 Stanford A used used no used
p7 m 54 Stanford A used used no used
p8 m 52 Stanford A used used used used
p9 f 58 Stanford A no no no used
p10 m 60 Stanford A no no no used
c1 m 65 Control used used used used
c2 f 45 Control used used used used
c3 m 40 Control used used used used
c4 f 44 Control used used used used
c5 m 23 Control used used no used
c6 f 42 Control used used no used
c7 m 42 Control used used no used
c8 f 54 Control used used no noJournal of Translational Medicine 2006, 4:29 http://www.translational-medicine.com/content/4/1/29
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The resulting table containing data for both normaliza-
tion methods is available on the Website Cancer today
[43].
Affymetrix human genome U133A GeneChip
The preparation and processing of labeled and frag-
mented cRNA targets as well as GeneChip hybridization
and scanning was carried out according to the manufac-
turer's protocol (Affymetrix, Santa Clara, CA, USA) as
described elsewhere [15]. Starting material for the labe-
ling procedure was 5 μg of total RNA from each aortic
specimen, and the labeling procedure was limited to one
cycle of in vitro transcription. Synthesized and fragmented
cRNAs were analyzed by electrophoresis using LabChips
on Agilent 2100 Bioanalyzer. After washing and staining
steps, arrays were scanned with Gene Array scanner 2500
(Affymetrix). Hybridization intensity data were automati-
cally acquired and processed by Affymetrix Microarray
Suite 5.0 software. The expression level (average differ-
ence) for each gene was determined by calculating the
average of differences in intensity (perfect match-mis-
match) between its probe pairs as described elsewhere
[16]. In order to normalize for sample loading and stain-
ing variation, the average fluorescent intensities of all
hybridization probes on an individual array were scaled
to fixed target signal intensity TGT of 100 relative signal
units (RSU).
The study reported in our manuscript complies with the
Minimum Information About a Microarray Experiment
(MIAME) guidelines established by the Microarray gene
expression data society http://www.mged.org.
Quantitative Real-Time PCR (RT-PCR)
We followed one of the most striking recent develop-
ments in the confirmatory studies issue [13] and authors
are informed about the latest discussion concerning estab-
lishing standards for microarray data annotation and rep-
resentation [17]. In order to validate an array results for
relevance, RT-PCR has been used.
Aliquots of the same total RNA as for microarray analysis
were used for quantitative RT-PCR. Validation of arrays
data has been performed for 24 differentially expressed
genes. All analyses were performed using the ABI PRISM
7900 Sequence Detection System (Applied Biosystems,
Foster City, CA, USA).
cDNAs for all PCR amplifications were generated by
oligo-dT primed reverse transcription (Superscript First
Strand System, Invitrogen Corporation, Carlsbad, CA,
USA). Primers and probes were designed by the manufac-
turer (Assays-on-Demand; Applied Biosystems, Foster
City, CA, USA). RPLPO (Hs 9999902m1) and cyclophilin
A (Hs 99999904m1) were selected as reference genes to
standardize the amount of sample RNA. The respective
primer/probes were prepared by mixing 25 μl of the 100
μM stock solution "upper primer", 25 μl of the 100 μM
stock solution "lower primer" with 12,5 μl of the 100 μM
stock solution TaqMan-probe (FAM/TAMRA) and
adjusted to 500 μl with H20 (primer/probe-mix). PCR
reactions using cDNA generated from 20 ng of total RNA
were performed in duplicates in a volume of 25 μl. This
includes TaqMan universal Master Mix (Applied Biosys-
tems) according to the manufacturer's protocols in 96-
well format and 1.25 μl of the Probe&Primer mix. Ther-
mal cycler parameters were 2 min at 50°C, 10 min at
95°C and 40 cycles, each consisting of a 15 s denaturation
step at 95°C and a 1 min annealing/extension step at
60°C. Relative abundance of a gene transcript was calcu-
lated by the ΔΔCt method.
Statistical analyses
Student's t-test
Mean values were calculated for each gene from the con-
trol and dissected cohorts of samples. Weak signals on the
array close to background result usually in unfavorable
signal-to-noise ratio and show low reproducibility
between experiments. Ratios of differential gene expres-
sion based on such values may be very high even when
there is no significant difference in the expression level of
the corresponding genes [14]. Therefore, only genes with
a mean expression value of at least 70% of the mean
expression of all genes spotted on the array, either in the
control or in the dissected aorta group, were used for sub-
sequent analyses. Genes were estimated as "differentially
expressed" in dissected and control aorta, if the mean
expression ratio of dissected and control aorta was less
than 0.6 or more than 1.8 for Human and Cardiovascular
filter arrays. For Affymetrix data, the same cut-off for mean
expression value of at least 70% of expression of all genes
per array has been applied. Since Affymetrix platform is
more precise and sensitive in detecting of signals corre-
sponding expressed mRNAs than arrays using radiola-
beled probes minimal fold change was set to 2.0 for
Affymetrix data. The unpaired Student's t-test was used as
appropriate with significance set at a P level of < 0.05 to
compare gene expression values for all three arrays. All t-
tests were two-sided.
Identification of differentially expressed genes using "Significance 
Analysis of Microarrays" (SAM)
Additionally, genes differentially expressed between dis-
sected and control aorta were identified using the signifi-
cance analysis of microarrays (SAM) software. The SAM
software is a statistical tool for finding significant genes in
a set of microarray experiments. Idea was proposed by
Tusher, Tibshirani and Chu [18]. This software was writ-
ten by B. Narasimhan and R. Tibshirani [43]. It is freely
available for academic organizations. It works as a Micro-Journal of Translational Medicine 2006, 4:29 http://www.translational-medicine.com/content/4/1/29
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soft Excel add-in. Control and dissected aorta datasets
were separated to corresponding blocks as recommended
by SAM procedure. Readers are referenced to the SAM
online manual for detailed explanations of the approach.
SAM applies some test statistic, for example, a t-statistic,
and then uses permutation to draw inferences. Shortly,
SAM calculates a statistic di for each gene i by measuring
the strength of the relationship between gene expression
and the class variable (control and dissected aorta). SAM
uses repeated permutations of the data to determine the
significant gene expression relating to the specific class.
The cutoff for significance is determined by a tuning
parameter  delta.  Delta  is the difference between the
observed score (t-statistics for the true labels), and the
average expected score (t-statistics for the randomly per-
mutated data). Delta is chosen by user based on the false
discovery rate (FDR). A fold change parameter can be cho-
sen to ensure the pre-specified amount of differential gene
expression. Fold change of gene expression is the ratio of
the mean expression levels for this gene in the groups
under comparison. User definable conditions were set to
default values. We applied two class unpaired comparison
with  t-statistics. Gene expression data were unlogged.
Value of k parameter in k-nearest-neighbor algorithm was
set to 3, number of permutations was 500. In these studies
the value of delta was always chosen so that estimated FDR
was a zero.
Partial least squares discriminant analysis for multivariate data (PLS-
DA)
We applied a direct linear discriminant analysis to com-
pare expression profiles of control and dissected aorta.
Supervised PLS-DA uses independent (expression levels)
and dependent variables (classes) for class comparison
applying multivariate statistical methods, namely the soft
independent modeling of class analogy (SIMCA) and par-
tial least squares modeling with latent variables to allow
simultaneous analysis of all variables [19-22]. Addition-
ally, PLS-DA provides a quantitative estimation of the dis-
criminatory power of each descriptor (gene) by means of
VIP (variable importance of the projection) parameters.
VIP values rank descriptors according to their ability to
discriminate different classes. PLS-DA was performed with
SIMCA-P commercially software (Umetrics AB, Umea,
Sweden) as described by Pérez-Enciso and Tenenhaus
[22]. Model validation was carried out via permutation.
Number of permutations was 100. Parameter Q2 is a
measure of the predictive ability of the model, and R2 is
related to the goodness of fit of the model.
Although the application of the t test for selection of genes
is appropriate because the number of defined classes is
limited to two [20], the VIP criterion used in PLD-DA is
more robust and discriminative. The PLS-DA is not ham-
pered by the problem of data that is not distributed per
normality; an assumption that has to be made for the
standard parametric t test. This assumption is rather more
important when working with relatively small numbers of
samples as in the present study.
Results
Identification of genes differentially expressed in dissected 
and control aorta, microarray analysis by different 
statistical methods
a. Unpaired t-test
BD Atlas™ human1.2 array
According to our definition (see section "Statistical analy-
ses" in Material and Methods) 229 of 1,185 genes
(19.3%) were expressed. Of those, 49 genes (21.4%) were
differentially expressed. Twenty-five genes showed higher
and 24 lower levels of gene expression in the dissected
compared with the control aorta.
BD Atlas™ human cardiovascular array
114 of 597 genes (19.1%) were estimated as being
expressed. Thirty-three genes (28.9%) displayed differen-
tial expression, 10 genes were up-regulated, whereas 23
genes were down-regulated in the dissected aorta.
Affymetrix HG-133A GeneChip
On the Affymetrix platform 5246 of 22,283 genes
(23.5%) showed detectable expression, of which 823
genes (15.7%) were differentially expressed in dissected
and control aorta. Of those, 323 genes showed higher and
500 genes lower expression in dissected aorta.
In table 2 all differently expressed genes of the Clontech
Atlas experiment are shown and compared to the Affyme-
trix experiment classified to several functional groups in
the similar way how it has been done in our first pub-
lished study [12]. Additionally to the differentially
expressed genes as observed by use of both Clontech Atlas
filter arrays, we included several significantly different
expressed genes of the Affymetrix experiment in order to
show functional groups to make it more informative for
common readers.
The direct comparison of differentially expressed genes
according to platforms of Clontech Atlas and Affymetrix
revealed a relatively high concordance between both data
sets. Thus, of those genes which have been found differen-
tially expressed on Clontech platform, 84% were also sig-
nificantly differentially expressed on the Affymetrix
platform. To illustrate this concordance, Affymetrix p val-
ues have been added to those genes reaching significance
on the Clontech Atlas arrays (Table 2). Additionally, genes
differentially expressed between dissected and control
aorta were identified using the significance analysis of
microarrays (SAM) software with 500 sample permuta-
tions [18].Journal of Translational Medicine 2006, 4:29 http://www.translational-medicine.com/content/4/1/29
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Table 2: Gene expression studies: dissected aorta ascendens vs. control aorta. Gene expression studies that comparing freshly 
dissected aorta ascendens (D) and undissected control aorta (C). 3 different gene expression studies were performed: 16 samples were 
studied with BD Atlas™ Human1.2 Array (h), 16 samples – with BD Atlas™ Human Cardiovascular Array (c) and 8 samples – with 
Affymetrix Human Genome U133A GeneChip. All differently expressed genes of the Atlas-experiments, 49 genes (h) and 33 genes (c), are 
shown and compared to genes of the Affymetrix experiment. Ratio: mean expression of dissected aorta (D) divided by mean expression 
of control (C); n.e.: not expressed, n.s.: difference not significant. n.t.: not tested, ↓ downregulated, ↑ upregulated; ? – regulation in the 
Atlas and Affymetrix experiment different
Gene Name Platform Atlas Affymetrix regulation
Functional group Array type ratio D/C P value ratio D/C P value
extracellular matrix proteins,
cell surface antigens, adhesion proteins
collagen IV α2, COL4A2 h 0.5 <0.01 0.4 <0.05 ↓
collagen IV α5, COL4A5 n.t. 0.32 <0.05 ↓
collagen VI α3, COL6A3 c 1.9 <0.05 n.s. ?
collagen VIII α1, COL8A1 c 0.3 <0.01 0.3 <0.001 ↓
collagen VIII α2, COL8A2 n.t. 0,4 <0,01 ↓
collagen XIV α1, COL14A1, undulin c 0.4 <0.001 0.5 <0.001 ↓
collagen XVIII α1, COL18A1 n.t. 0.47 <0.001 ↓
polycystin1, PKD1 h 0.3 <0.001 0.4 <0.01 ↓
polycystin 2, PKD2 n.t. 0.4 <0.001 ↓
clusterin, SP-40; h 0.5 <0.01 0.5 <0.01 ↓
integrin α7B, IGA7B h 0.4 <0.001 0.3 <0.001 ↓
gap junction protein, connexin 43 c 0.6 <0.05 n.s. ?
SPARC-like 1 c 0.3 <0.001 0.6 <0.001 ↓
decorin c 0.3 <0.05 n.s. ↓
elastin n.t. 0.4 <0.05 ↓
fibulin 5 n.t. 0.4 <0.001 ↓
cell surface glycoprotein MUC18 h 0.3 <0.001 0.5 <0.01 ↓
fibronectin receptor h n.s. 3.4 <0.01 ↑
ras homolog gene family member B h 0.5 <0.05 n.s. ?
extracellular matrix proteolysis
MMP-11 h 2.1 <0.001 3.2 <0.05 ↑
MMP-14 n.t. 2.5 <0.01 ↑
MMP-19 n.t. 3.2 <0.05 ↑
TIMP1 h,c 1.8 <0.01 n.s. ?
TIMP2 h,c 0.4 <0.01 n.s. ?
TIMP3 c 0.2 <0.001 n.s. ?
cell motility and cytoskeleton proteins
vinculin c 0.2 <0.001 n.s. ?
actinin α1 c 0.5 <0.001 0.8 <0.01 ↓
filamin A c 0.3 <0.001 0.5 <0.001 ↓
actin α2 n.t. 0.13 <0.001 ↓
actinin α4 n.t. 0.44 <0.001 ↓
gelsolin n.t. 0.5 <0.01 ↓
leiomodin n.t. 0.4 <0.01 ↓Journal of Translational Medicine 2006, 4:29 http://www.translational-medicine.com/content/4/1/29
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tropomyosin 1 n.t. 0.4 <0.01 ↓
calponin n.t. 0.3 <0.001 ↓
smooth & non-muscle myosin light chain kinase h 0.4 <0.001 n.t. ↓
smooth muscle myosin heavy chain, SM2 n.t. 0.5 <0.001 ↓
myosin regulatory light chain2, smooth muscle n.t. 0.5 <0.001 ↓
metabolism n.t.
low-density lipoprotein receptor, LDLR c 0.4 <0.001 1.6 <0.01 ?
Kunitz-type serine protease inhibitor 2, SPINT2 h 0.2 <0.001 0.3 <0.001 ↓
aldehyde dehydrogenase 2, mitochondrial c 0.3 <0.01 0.6 <0.01 ↓
diaphorase (NADH), cytochrome b-5 reductase c 0.5 <0.01 n.s. ?
superoxide dismutase 3, extracellular c 0.4 <0.01 0.4 <0.001 ↓
lipase A c 2.6 <0.05 n.s. ?
protease inhibit, PI1, alpha-1-antitrypsin h 5.5 <0.001 ↑
GABA-B receptor 1A subunit h 1.8 <0.001 n.e. ?
prostaglandin I2 prostacyclin synthetase c 0.4 <0.05 0.81 <0,001 ↓
Gene Name Platform Atlas Affymetrix regulation
Functional group Array type ratio D/C P value ratio D/C P value ratio D/C
Protein turnover
purine-rich element-binding protein A h 0.4 <0.01 0.6 <0.05 ↓
glutathione S-transferase theta 1 h 0.4 <0.01 0.2 <0.05 ↓
58-kDa inhibit. of RNA-activated protein kinase h 0.3 <0.01 ↓
G1/S-specific cyclin D1 h 0.5 <0.01 n.s. -
carboxypeptidase H, CPE; enkephalin convertase h 0.4 <0.01 ↓
ribos. protein S6 kinase II α1, S6KII-alpha 1 h 3.1 <0.001 n.s. -
carboxypeptidase N, polypeptide 1, 50 kD c 2.0 <0.05 n.e. -
eukariotic translation initiantion factor 4E bind prot 1 n.t. 2.9 <0.01 ↑
60 S acdic ribosomal protein PO n.t. 3.0 <0.01 ↑
FOS-related antigen 1 h,c 4.9 <0.01 3.6 <0.05 ↑
myc proto-oncogene h 3.5 <0.01 2.8 <0.05 ↑
ets domain protein elk-3; NET; SRF accessory protein h 2.1 <0.001 4.4 <0.05 ↑
adenine phosphoribosyltransferase n.t. 2.1 <0.001 ↑
high mobility group prot isoforms I & Y, HMGIY h 10.1 <0.001 6,0 <0.01 ↑
superoxide dismutase 2, mitochondrial c 2.6 <0.01 3.7 <0.001 ↑
Cell receptors
Natriuretic peptide receptor A/guanylate cyclase A c 0.4 <0.001 0.3 <0.001 ↓
natriuretic peptide receptor C/guanylate cyclase C c 0.5 <0.001 n.s. -
protein tyrosine phosphatase receptor type F c,h 0.4 <0.01 n.t. -
growth factors
Table 2: Gene expression studies: dissected aorta ascendens vs. control aorta. Gene expression studies that comparing freshly 
dissected aorta ascendens (D) and undissected control aorta (C). 3 different gene expression studies were performed: 16 samples were 
studied with BD Atlas™ Human1.2 Array (h), 16 samples – with BD Atlas™ Human Cardiovascular Array (c) and 8 samples – with 
Affymetrix Human Genome U133A GeneChip. All differently expressed genes of the Atlas-experiments, 49 genes (h) and 33 genes (c), are 
shown and compared to genes of the Affymetrix experiment. Ratio: mean expression of dissected aorta (D) divided by mean expression 
of control (C); n.e.: not expressed, n.s.: difference not significant. n.t.: not tested, ↓ downregulated, ↑ upregulated; ? – regulation in the 
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vascular endothelial growth factor, VEGF h 4.7 <0.05 n.s. -
endothelin 2 c 0.6 <0.01 n.e. -
fibroblast growth factor receptor1 h 0.6 <0.01 0.7 <0.05 ↓
insulin-like growth factor-binding protein 2, IGFBP2 h 0.3 <0.001 0.2 <0.01 ↓
cardiotrophin 1 c 0.4 <0.001 0.5 >0.05 ↓
pleiotrophin, heparin-binding growth factor 8, HBGF8 h 0.5 <0.05 0.6 <0.05 ↓
inflammation + stress response
colony-stimulating factor 1 receptor, CSF1R h 2.0 <0.05 1.7 <0.05 ↑
myeloid cell nuclear differentiation antigen h 3.5 <0.001 3.9 <0.05 ↑
tumor necrosis fact recept superfam memb 1B h 2.0 <0.001 n.s. -
granulocyte colony stimul factor recept h 3.5 <0.01 n.e. -
interleukin 2 receptor alpha subunit, IL-2, CD25 antigen h 3.1 <0.001 5.3 <0.001 ↑
interleukin 6, IL-6 h 3.9 <0.01 4.3 <0.001 ↑
interleukin 8, IL-8 12.2 <0.05 ↑
small inducible cytokine subfamily A member 2 h,c 3.8 <0.01 2.2 <0.05 ↑
90-kDa heat-shock proteinA HSP90A h 2.6 <0.05 n.t. ↑
60-kDa heat shock protein HSP60 h 2.7 <0.05 n.t. ↑
CD9 antigen p24 c 0.5 <0.001 0.5 <0.01 ↓
27-kDa heat shock protein HSP27 h 0.4 <0.001 n.t. -
blood, hemostasis
endothelial plasminogen activator inhibit 1, PAI1 h 2.8 <0.05 4.0 <0.05 ↑
thrombomodulin h 2.8 <0.05 n.s. -
hexabrachion, tenascin C c 2.6 <0.01 6.2 <0.05 ↑
heme oxygenase 1 h 15.4 <0.05 3.6 <0.05 ↑
tissue factor pathway inhibit, coagulation inhibit c 2.0 <0.05 1.6 <0.05 ↑
tissue factor pathway inhibitor 2 c 2.3 <0.05 3.0 <0.05 ↑
others
c-fgr proto-oncogene p55-FGR h 2.6 <0.01 2.6 <0.01 ↑
erbB3 proto-oncogene; HER3 h 3.7 <0.001 n.t. ↑
caspase 4 h 1.9 <0.05 n.t. ↑
follistatin-related protein h 0.5 <0.01 0.6 <0.01 ↓
Gem; induced immediate early protein h 0.2 <0.001 0.3 <0.001 ↓
parathymosin athymosin h 0.6 <0.05 0.8 n.s. -
prostaglandin I2 (prostacyclin) synthase c 0.4 <0.05 n.t. <0.001 ↓
calcium-activated potassium channel beta subunit h 0.3 <0.001 0.4 <0.01 ↓
solute carrier fam 4 anion exchanger member 3 c 0.5 <0.001 n.t. -
Table 2: Gene expression studies: dissected aorta ascendens vs. control aorta. Gene expression studies that comparing freshly 
dissected aorta ascendens (D) and undissected control aorta (C). 3 different gene expression studies were performed: 16 samples were 
studied with BD Atlas™ Human1.2 Array (h), 16 samples – with BD Atlas™ Human Cardiovascular Array (c) and 8 samples – with 
Affymetrix Human Genome U133A GeneChip. All differently expressed genes of the Atlas-experiments, 49 genes (h) and 33 genes (c), are 
shown and compared to genes of the Affymetrix experiment. Ratio: mean expression of dissected aorta (D) divided by mean expression 
of control (C); n.e.: not expressed, n.s.: difference not significant. n.t.: not tested, ↓ downregulated, ↑ upregulated; ? – regulation in the 
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b. Identification of genes of interest by SAM
Human and Cardiovascular cDNA arrays' (Clontech plat-
form) data were used as normalized previously. Signifi-
cant genes were selected independent of their expression
levels when their score was above the specified threshold
delta. With a FDR of 0 and by applying a minimal fold-
change of 1.8 the analyses revealed consistent patterns of
differential gene expression. In total, 37 genes were signif-
icantly differentially expressed, i.e., 23 genes were up- and
14 genes were down-regulated in dissected aorta samples
as defined by Human cDNA array (Additional file 1).
Additionally, 36 genes were differentially expressed, i.e.,
three genes were up- and 33 genes down-regulated in dis-
sected aorta samples as defined by Cardiovascular array
(Additional file 2). Applying SAM to Affymetrix data we
firstly had to reduce the number of genes under analysis.
Since the signal detection is much more precise for
Affymetrix data than in case of Atlas filter arrays, we
changed the cutoffs for the detectable differential gene
expression and set the cutoff for minimal expression level
to 30 RSU. 30 RSU is an absolute board line (TGT = 100)
for signal detection on GeneChip, which we accept as
measurable. We selected 11,128 expressed genes, and
SAM has been used with a FDR of 0, and a minimal fold-
change of 2.5 has been then applied. In total, 195 genes
were significantly differentially expressed between dis-
sected and control aorta. Of those, 60 were up-regulated
and 135 were down-regulated (Additional file 3).
c. Partial least squares discriminant analysis (PLS-DA)
We evaluated the discriminative ability of PLS-DA ques-
tioning for small gene sets to separate control and dis-
sected aorta samples. Expression data obtained on the
Human Atlas array were used in the PLS-DA analysis,
which were carried out in the first iterative level with all
281 reliably expressed genes previously used in the t test.
During the course of analysis, we selected those genes sat-
isfying the cutoff criterion of having the variable impor-
tance in the projection (VIP) more than 1.5 with the first
PLS component. In a second iterative PLS-DA only these
genes (n = 44) were reanalyzed to avoid running an over-
fitted model (see genes listed in Additional file 4). The VIP
values (Additional file 4) correspond to the model with
selected 44 genes and display lower values than obtained
in the model with all 281 genes. This phenomenon has
been reported previously [18,19]. To demonstrate a good
agreement between both statistical analyses, t-test and
PLS-DA, we included t-test's P values alongside with in-
between groups ratios into the Additional file 4. Results of
PLS-DA analyzing the 44 selected genes are depicted in
Fig. 1A. Apparently control and dissected aorta samples
are clearly discriminated. We performed a permutation
test for the model covering only 44 genes, which showed
the robustness and precision of this model (Additional
file 7).
Furthermore, we applied PLS-DA to the 149 reliably
expressed genes, as detected on the Cardiovascular array
(Clontech). After the analysis with one PLS component
had been performed, we retained 30 genes with highest
VIP values between 1.8 and 1.32 for the second iterative
PLS analysis run. Fig. 1B shows PLS-DA scatter plot with
one component perfectly subdividing control and dis-
sected aorta samples. Selected genes are listed in Addi-
tional file 5. An independent permutation test showed
that model with selected genes was the one with the high-
est predictive power (Additional file 7).
For the Affymetrix platform, PLS-DA was carried out on
the original 11,128 probe sets that passed the QC filtering
process. Although this process may lead to an over param-
eterized model with poor prediction properties, it pro-
PLS-DA between control and dissected aorta samples Figure 1
PLS-DA between control and dissected aorta samples. A, PLS 
discrimination with the 44 genes with VIP > 1.5 – Human 
Broad I array (Clontech). B, PLS discrimination with 30 genes 
with VIP > 1.32 – Cardiovascular array (Clontech). C, PLS 
discrimination with 79 genes with VIP > 1.51 – Affymetrix 
GeneChip microarray. Horizontal axis, number of samples in 
the table; vertical axis, the first PLS component. Numbers next 
to the black squares and rhombus, refer to control "c" or dis-
sected "p" aorta samples.
A
B
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vides a preliminary assessment of the most important
discriminative variables. Further, those variables satisfy-
ing the criteria of minimal ratio of 2.5 were retained and
with the highest VIP values ranging from the maximum of
1.56 to 1.51 in the first iterative PLS analysis (Additional
file 6). From those, 79 genes were selected, which demon-
strated the highest predictive power (Fig. 1C), as shown by
permutation analysis (Additional file 7).
d. Comparison between three statistical methods
Since t-test may be problematic in multiple testing we
applied "Significance analysis of microarrays" (SAM) and
"Partial least squares discriminant analysis" (PLS-DA) to
three data sets obtained by use of Human, Cardiovascular
and Affymetrix GeneChip arrays. All three statistical meth-
ods were adequate in capturing a small number of the
potentially relevant genes to the disease. We found the
agreement between three statistical methods very high for
all three array types. We have summarized the agreement
between the three methods for each of used array type in
the Table 3. Thus, we found 31 genes being differentially
expressed between dissected and control aorta samples by
applying the t-test to data obtained with Cardiovascular
array. SAM analysis assorted 36 differentially expressed
genes. Of those, 27 genes were on the t-test list. PLS-DA
found 34 genes, which were sufficient to discriminate
between both groups of samples. Of those, 26 genes were
identified by the t-test.
We performed the new t-test analysis for the Affymetrix
data by setting another cutoff values. Additionally to the
board line of 30 RSU for the detectable gene expression,
minimal fold change was set to 2.5 for Affymetrix data
and cut-off for P-value was < 0.01 for the t-test. Under this
assumption 11,128 of 22,283 genes (50%) showed
detectable expression on the Affymetrix platform, of
which 242 genes (21.8%) were differentially expressed in
dissected and control aorta with 89 genes showed higher
and 153 – lower expression in dissected aorta. Of those,
195 genes were found by SAM. Consequently, 79 genes,
which are the part of 195th and 242nd gene sets, were inde-
pendently extracted by PLS-DA, as sufficient to discrimi-
nate between normal and diseased aorta samples.
Therefore, expression profiling of dissected and control
aorta revealed significant differences in expression levels
of certain genes.
Availability of raw expression data
Raw data for Clontech Human, Cardiovascular, and nor-
malized expression data for Affymetrix HG-133A arrays
have been submitted as Additional files 8, 9, 10 in Excel
format.
Validation of some genes differentially expressed in 
dissected and control aorta by TaqMan real-time PCR
We selected a subset of 24 genes that were influenced by
aortic dissection process for confirmation using quantita-
tive real-time PCR. All chosen genes encode for proteins,
which are important for the aortic structure and function.
Confirming the microarray data, we found that almost all
genes except of hypoxia-inducible factor 1 (HIF1α) and
metalloproteinase -11 (MMP-11) were up- or down-regu-
lated in dissected samples (Table 4). Pearson correlation
analysis revealed a significant correlation between the
cDNA or oligonucleotide array data and real-time PCR
data for expression changes. Notably, Affymetrix array
and real-time PCR data showed on the average higher cor-
relation than that obtained on the Atlas Clontech plat-
form.
Gene groups with predominant down-regulation in 
dissected aorta
Differentially expressed genes could be subdivided into
several functional groups (Table 2).
Extracellular matrix (ECM)
Several genes that encode for extracellular matrix proteins
displayed lower expression in dissected aortic wall relative
to normal aortic wall (Table 2). Collagen distribution on
the Atlas Clontech arrays: Whereas the mRNA of collagen
1, -IV α1, -XV, -XVI were equally distributed in dissected
and control aorta, collagen II, -III, -IV α6, -V, -IX, -XVIII, -
Table 3: The level of agreement between the t test, SAM and PLS-DA for selecting differentially expressed genes from the same data 
set.
Type of array N.o. of differently expressed genes between 
dissected and control aorta
Agreement between all 
three methods
t-test P < 0.01 SAM PLS-DA
Human Broad I cDNA array 43 37 35 29
Agreement with t-test - 29 (67%) 35 (81%) -
Cardiovascular cDNA array 31 36 34 22
Agreement with t-test - 27 (87%) 26 (84%) -
Affymetrix HG-133A 242 195 79 79
Agreement with t-test - 195 (81%) 79 (33%) -Journal of Translational Medicine 2006, 4:29 http://www.translational-medicine.com/content/4/1/29
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XIX were not expressed on the cardiovascular membrane.
However, genes for collagen VI α3, -VIII α1, -VIII α2, – XIV
showed a lower gene expression in dissected compared to
control aorta. Collagen distribution on the Affymetrix
chip: The Affymetrix chip displayed similar collagen gene
expressions compared to the Atlas experiment. Genes for
collagen IV α2, -IV α5, -VIII α1, -VIII α2, -XV, -XVIII α1
displayed a lower gene expression in dissection, whereas
RNAs for collagen I, -III, -IV α1, -V and -VI were equally
distributed, while the other collagens did not show any
significant levels of gene expression. The lower gene
expression of collagen VIII was also confirmed by RT-PCR.
The mRNA of gene for elastin, an important connective
tissue fiber, was reduced in dissected aorta, which was val-
idated by RT-PCR.
Cytoskeleton and myofibrillar genes
Another group of genes with decreased expression levels
consists of cytoskeleton and myofibrillar genes. We found
that expression of α-actin gene, actinin α2 and -α4, tropo-
myosin, gelsolin and some myosin light and heavy chains
were down-regulated in dissected aorta compared to nor-
mal control aorta.
Cell-cell adhesion
Expression levels of genes, such as gene for fibulin 5 and
integrin α7B, cell surface glycoprotein MUC18 and poly-
cystin 1 and -2 coding for cell-cell adhesion proteins were
significantly lower in the dissected aorta.
Matrix metalloproteinases and their inhibitors
Despite the connective tissue components had shown
similarity in their expression levels and degree of differen-
tial gene expression on both array platforms, the expres-
sion of the matrix metalloproteinases (MMP) and their
inhibitors was less uniform. On the Affymetrix platform
only MMP-14 and MMP-19 were up-regulated, whereas
MMP-2 and MMP-9 were equally expressed in dissected
and control aorta. Genes of other metalloproteinases were
not expressed. TIMP1, TIMP2, and TIMP3 were consist-
ently expressed in both, dissection and control. In con-
trast, expression of MMP-11 and TIMP1 was up-regulated
Table 4: Correlation of Clontech/Affymetrix gene expression levels with TaqMan real-time RT-PCR derived values. C means Clontech 
array (BD Atlas™ Human1.2 Array or BD Atlas™ Human Cardiovascular Array, A means Affymetrix Human Genome U133A GeneChip, 
MLCK * = myosin light chain kinase, MHCP 11** = myosin heavy chain polypeptide 11, KCNMB1*** = calcium-activated potassium 
channel beta, APEG1**** = Homo sapiens nuclear protein, HIF1α***** = hypoxia-inducible factor 1, alpha subunit.
Gene Name Array ABI Hs code GenBank Pearson correlation Ratio (D/C) array Ratio (D/C) RT-PCR
rP
collagen VIII α1 C 00156669m1 X57527 0.626 8.36E-03 0.27 0.23
PKD1 C 00165489m1 U24497 0.497 4.78E-02 0.31 0.43
PKD2 C 00165517m1 U50928 0.655 5.11E-03 0.37 0.19
tenascin C C 00233648m1 X78565 0.789 1.96E-04 2.56 5.68
elastin C 00355783m1 M36860 0.676 3.42E-03 0.33 0.14
integrin α5 C 00233743m1 X06256 0.679 3.21E-03 3.5 1.93
decorin C 00370385m1 M14219 0.715 1.48E-03 0.34 0.61
fibulin 5 A 00197064m1 AF112152.1 0.852 6.21E-07 0.47 0.16
MUC18 C 00174838m1 M28882 0.883 2.77E-06 0.31 0.18
MMP11 C 00171829m1 X57766 -0.036 0.89 2.1 0.57
TIMP2 C 00234278m1 J05593 0.521 3.63E-02 0.41 0.53
TIMP3 C 00165949m1 U14394 0.794 1.63E-04 0.2 0.47
vinculin C 00243320m1 M33308 0.807 1.04E-04 0.22 0.31
actin α2 A 00426835g1 J05192.1 0.965 2.77E-12 0.52 0.19
actinin α4 A 00245168m1 U48734.1 0.946 1.03E-10 0.44 0.19
filamin A C 00155065m1 X53416 0.874 4.91E-06 0.33 0.09
MLCK * C 00178736m1 U48959 0.741 7.80E-04 0.36 0.19
MHCP 11** A 00224622m1 NM0228 0.580 9.57E-03 0.48 0.09
leiomodin 1 A 00201704m1 BC001755.1 0.979 4,23E-14 0.43 0.19
heme oxygenase 1 C 00157965m1 X06985 0.837 3.09E-05 8.47 6.58
KCNMB1*** C 00188073m1 U25138 0.763 4.31E-04 0.29 0.29
calponin 1 A 00154543m1 U37019.1 0.985 2.76E-15 0.31 0.13
APEG1* *** A 00195347m1 U57099.1 0.854 5.51E-07 0.58 0.19
HIF1α***** A 00153153m1 U22431.1 -0.932 0.27 1.7 1.86Journal of Translational Medicine 2006, 4:29 http://www.translational-medicine.com/content/4/1/29
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in dissection, as found on Clontech platform, whereas
TIMP2 and TIMP3 were down-regulated. The differential
expression of both, TIMP2 and TIMP3 was confirmed by
real time PCR.
Gene groups with predominant up-regulation in dissected 
aorta
Inflammation and apoptosis
Expression of several genes associated with inflammation
processes, e.g. genes coding for the inflammatory chem-
okines, as interleukines (IL), IL-2, IL-6 and IL-8, were up-
regulated in dissected aorta. Some stress response genes,
as 90-kDa heat-shock protein A (HSP90A), HSP60, and
HSP27  were also up-regulated in dissection. Only one
gene related to apoptosis, caspase 1 was up-regulated in
dissection.
Blood and hemostasis
Genes of some blood components and components of
coagulation and lysis pathways, for example, gene for
heme oxygenase 1, endothelial plasminogen activator
inhibitor, PAI1 or thrombomodulin were up-regulated in
the freshly dissected aorta.
Proliferation, transcription and translation
We observed differential expression of some genes related
to cell growth in dissection and normal aorta, some genes
were up-regulated, others down-regulated.
Discussion
Molecular features underlying the pathogenesis of aortic
dissection are still enigmatic. Knowledge of the differen-
tial gene expression in dissected compared to the normal
aorta may help to identify candidate genes for further
studies allowing insights into the pathogenesis of aortic
dissection. We proposed that some stable disfunctions in
gene expression may underlie the development of aortic
dissection. Sixty-six differentially expressed genes have
been found and described in our previous study of aortic
dissection [12]. Up-regulated genes in aortic dissection
were involved in inflammation, extracellular matrix pro-
teolysis, proliferation, transcription and translation proc-
esses. Down-regulated genes coded for extracellular
matrix, adhesion and cytoskeletal proteins. Although the
differences were significant, insufficient number of genes
on the cDNA array and the absence of any verification of
differential gene expression made the results of prelimi-
nary character.
In the present study we analyzed the gene expression in
the aortic wall of acute Stanford A dissection and com-
pared it with normal control aorta using two different
microarray platforms followed by independent verifica-
tion by real-time RT-PCR. We followed different strategies
to study aortic dissection further and verify our previous
and new findings concerning differentially expressed
genes. First of all, we collected new tissue samples.
Whereas multiorgan donors in our pilot study were signif-
icantly younger than patients with aortic dissection dis-
ease, we brought the age of both groups into line. The
samples were analyzed with the previously used cDNA
array (Atlas Human Broad I). Additionally, we used the
Atlas Human Cardiovascular array containing probes for
genes, which are highly specific for cardiovascular sys-
tems. Since some genes were in common on both Clon-
tech filter arrays, an internal control was possible to verify
the results from the Clontech platform. As a further result,
we found the same genes being up- or down-regulated
compared with our first study, thus confirming the find-
ings from our pilot study [12]. Although data on expres-
sion profiles of control and dissected aorta has been
confirmed between groups and arrays used in both stud-
ies, pilot and the present one, the further extension of
genes under analysis was definite necessarily.
Eight samples, four aortic samples obtained from patients
with type A acute aortic dissection and four control sam-
ples obtained from multiorgan donors, were studied on
Affymetrix microarrays with more than 22,000 features
corresponding human genes/ESTs. About 60% of the
genes with altered expression in the dissected versus nor-
mal aorta were down-regulated in the dissected aorta. An
interesting observation is the high percentage of down-
regulated genes that are related to extracellular matrix, cell
to cell adhesion, and cytoskeleton structures. It suggests
that pathology of aortic dissection results from a loss of
gene function. Smooth muscle cells (SMCs) in the media
where the dissection occurs either seem to produce less
proteins maintaining the stability of the aortic wall struc-
ture, or the number of SMCs themselves expressing these
genes is reduced [23,24].
Extracellular matrix (ECM)
The human aorta consists of three distinct layers: tunica
intima, tunica media, and tunica adventitia. The media
where the dissecting process takes place is the thickest
layer in cross section and contains fenestrated elastin sep-
arated by smooth muscle cells, collagen chains and
ground substance such as proteoglycans and glycopro-
teins [25-27]. Human aorta contains 12–24 g collagen
and 28–32 g elastin per 100 g tissue [26]. Whereas colla-
gen fibers provide strength and resistance to stretching,
elastin provides elasticity and is very essential in the
ascending aorta especially close to the heart [24-29]. The
major types of collagen found in dissected and control
aorta are collagen I and III [30-32]. Type IV collagen, the
major component of basement membranes and basal
laminae surrounding smooth muscles and nerves
[26,29,30], is a family of six homologous chains (α1–α6)
that have tissue-specific distribution. Heavily thickenedJournal of Translational Medicine 2006, 4:29 http://www.translational-medicine.com/content/4/1/29
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type IV collagen structures surrounding individual
smooth muscle cells were found in fibrous plaques but
never in unaffected intima [30,31]. The chains of type IV
collagen are assembled into supramolecular networks that
differ in the chain composition. Six chains of type IV col-
lagen are distributed in three major networks α1/α2, α3/
α4/α5, and α1/α2/α5/α6 [32].
Gene expression of collagen IV α2 and -α5 was down-reg-
ulated in the dissected aorta. Sariola [33] had already
shown defects in type IV collagen around medial smooth
muscle cells when analyzing dissected aorta by immuno-
histochemistry. Defects in smooth muscle cell basal lami-
nae were found throughout the media in cystic medial
degeneration and in medionecrosis. Similar to our exper-
iment no defects in the expression of interstitial collagens
type I and III were seen in the dissecting aortas. The
authors concluded that local changes in the basement
laminae of the medial layer are important in the patho-
genesis of the aortic dissection. This observation was con-
firmed by Ishii and Asuwa who also compared dissected
and normal aortic wall by immunohistochemistry [34].
They also detected a significant higher concentration of
MMP-2 and MMP-9 proteins at the beginning of dissec-
tion near the „entry" whereas in intact areas of the same
aorta MMP-2 and MMP-9 proteins were not increased. We
did not observe any differential expression of MMP-2 and
MMP-9 in dissected and control aorta. A possible explana-
tion is that our gene expression studies considered the
whole aortic wall and not especially the „entry site" of the
dissection.
Apart from collagen IV we found a decreased gene expres-
sion of collagen XVIII and of the proteoglycan decorin in
the dissected aorta, which proteins have a high affinity to
collagen I and III fibrils.
Studies of aortic aneurysms have already shown a signifi-
cant reduction of elastin content in the diseased aortic
wall, which probably occurs due to a high elastase activity
[35,36]. We were also able to demonstrate a reduced gene
expression of elastin in dissection nevertheless in contrast
to aneurysmal degradation, we could not detect elastase
(MMP-12) expression on the array. On the contrary, our
Affymetrix experiments showed a higher gene expression
of the matrix metalloproteinases 11,-14 and -19. MMP-11
and MMP-14 degrade fibronectin and proteoglycanes,
and MMP-14, additionally, – the major collagens I-III
[37]. MMP-19, a recently discovered member of the zinc-
dependent proteolytic enzymes, is able to process various
proteins of the basement membranes [38,39]. Titz and
colleagues treated tumor extracellular matrix with recom-
binant MMP-19 and analyzed its effect on capillary like
formation [39]. MMP-19 preferentially cleaves nidogen-1,
which interferes with its cross link abilities for extracellu-
lar matrix proteins, especially laminin-1 and type IV colla-
gen. As a consequence, the capillary-like structure
formation was inhibited. The authors concluded that
MMP-19 might be one of the enzymes that interferes with
stabilization or maturation of nascent vasculature. We
believe that MMP-19 might play a key role in propagating
dissection by degrading type IV collagen in the vasa vaso-
rum and the basal laminae surrounding smooth muscle
cells in the media.
The ECM contains many glycoproteins which bind to cell
surface components, and mediate cell-matrix connections
and cell to cell contacts [26]. We detected decreased
expression levels of some of these genes in the dissected
aorta, for example, genes coding for fibulin 5, cell surface
glycoprotein MUC18, SPARC-like 1 (osteonectin), clus-
terin and connexin 43. Additionally, expression of several
integrin genes was also decreased in diseased aorta.
Integrins are adhesion receptors on the cell surface. Tissue
remodeling is dependent on integrin-matrix signaling and
interaction [27].
In our pilot study [12] we described that expression of
polycystin 1 was lower in dissected aorta samples. In the
present study we observed decreased expression of both
genes for polycystin 1 and -2. Polycystins function as
matrix receptors to link ECM to the actin cytoskeleton via
focal adhesion proteins [40,41]. Mutations of these genes
cause autosomal dominant polycystic kidney disease and
familiar clustering of aortic dissection events, and
supraaortal dissection or cerebral artery aneurysm in this
disease have already been described [42].
Smooth muscle and cytoskeleton proteins
We noticed reduced expression levels of some myofibril-
lar genes belonging to the contractile system of smooth
muscle cells in dissection. A possible explanation could be
a depletion of smooth muscle cells in the media of the dis-
sected aorta. However, loss of contractility means reduced
strength in resisting to pulsating hemodynamic forces.
The cytoskeleton is a dynamic intracellular network influ-
encing cell morphology and motility as well as intracellu-
lar transport. The cytoskeleton is composed of three
principal types of protein filaments: actin filaments, inter-
mediate filaments and microtubuli. The major cytoskele-
tal protein in most cells is actin, which polymerizes to
form actin filaments (microfilaments). These filaments
are organized in actin bundles. Actin binds a lot of cross-
linking proteins [27]. In our studies gene expression of
actin  α2 itself and some of the actin-binding proteins
(actinin α1 and -α4, vinculin, gelsolin, filamin A, macro-
phin or actin binding protein ABP620) were reduced in
dissection.Journal of Translational Medicine 2006, 4:29 http://www.translational-medicine.com/content/4/1/29
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Inflammation
A lot of genes being involved in inflammation were up-
regulated in the dissected aorta, e.g., the inflammatory
chemokines  IL-2,  IL-6  and  IL-8, or integrin αM and
integrin α2, which bind to lymphocytes or macrophages.
Protein turnover
Our recent pilot study had shown an upregulation of sev-
eral genes being involved in cell proliferation and consid-
ered this as result of an injury and repair mechanism [12].
In our new comparative gene expression studies some
transcription and translation factors were up-regulated,
whereas others were down-regulated.
Blood and hemostasis
Some genes being substantially important for blood cells
as heme oxygenase 1 or for blood coagulation and lysis
such as endothelial plasminogen activator inhibitor 1
were up-regulated in dissection. This may be a conse-
quence of the dissection process itself. In our recent study
we have compared nondissected and dissected aortic wall
areas of the same tissue sample and had found no signifi-
cant difference in their gene expression patterns [12]. Nev-
ertheless, Stanford A patients undergo emergency surgery
within 24 h after acute dissection and there may be some
blood components left in the tunica media.
Conclusion
Although the clinical significance of the present study can-
not be definitely estimated yet, the data on differential
gene expression illustrate the underlying biological proc-
esses involved in aortic dissection formation. Gene
expression studies comparing acutely dissected ascending
aorta and normal control aorta have shown major differ-
ences. Whereas some genes mediating inflammation were
up-regulated in dissection, a lot of genes mediating stabil-
ity and integrity of the aortic wall were down-regulated.
Aortic dissection seems to be the dramatic endpoint of a
longer lasting process of degeneration and insufficient
remodeling of the aortic wall. Expression profiling of aor-
tic dissection was capable of detecting biologically impor-
tant changes in gene expression, which are probably
associated exclusively with aortic dissection with excellent
fidelity while revealing important down-stream effects of
tissue remodeling and dysfunction of aortic structures for
future in-depth studies. Indeed, we already examined the
expression and localization of some extracellular matrix
components, cytoskeleton and adhesion proteins in a fur-
ther immunohistochemical study of normal and dissected
aorta (manuscript in preparation).
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